DENTSPLY SIRONA (NASDAQ:XRAY) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) from a hold rating to a buy rating in a report issued on Friday morning.

XRAY has been the subject of several other research reports. Mizuho assumed coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a "neutral" rating and a $21.00 price target for the company. Morgan Stanley cut their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a report on Tuesday, December 17th. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating for the company in a report on Friday, November 8th. UBS Group dropped their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a research note on Tuesday, December 3rd. Finally, Barrington Research decreased their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating for the company in a research report on Friday, November 8th. Nine analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $26.33.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY traded down $0.14 during mid-day trading on Friday, hitting $18.33. The company's stock had a trading volume of 803,290 shares, compared to its average volume of 2,272,829. The business's fifty day moving average is $19.09 and its two-hundred day moving average is $22.13. The stock has a market cap of $3.64 billion, a price-to-earnings ratio of -8.85, a PEG ratio of 1.83 and a beta of 0.96. DENTSPLY SIRONA has a 1 year low of $17.21 and a 1 year high of $34.91. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 3.49%. The ex-dividend date of this dividend was Friday, December 27th. DENTSPLY SIRONA's payout ratio is -30.92%.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently modified their holdings of XRAY. Pacer Advisors Inc. raised its stake in DENTSPLY SIRONA by 15,105.1% during the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock worth $85,478,000 after purchasing an additional 4,473,972 shares during the period. Cooke & Bieler LP raised its stake in DENTSPLY SIRONA by 24.3% during the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock worth $174,101,000 after purchasing an additional 1,794,391 shares during the period. JPMorgan Chase & Co. raised its stake in DENTSPLY SIRONA by 206.3% during the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after purchasing an additional 1,244,326 shares during the period. American Century Companies Inc. raised its stake in DENTSPLY SIRONA by 38.2% during the fourth quarter. American Century Companies Inc. now owns 3,873,645 shares of the medical instruments supplier's stock worth $73,522,000 after purchasing an additional 1,071,604 shares during the period. Finally, Invenomic Capital Management LP purchased a new position in DENTSPLY SIRONA during the third quarter worth approximately $23,724,000. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.